Gevo - GEVO Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Gevo in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GEVO shares.
View GEVO analyst ratings or view top-rated stocks.

2 brokers have issued twelve-month price objectives for Gevo's shares. Their GEVO share price forecasts range from $5.00 to $10.00. On average, they predict the company's share price to reach $7.50 in the next year. This suggests a possible upside of 108.3% from the stock's current price.
View analysts price targets for GEVO or view top-rated stocks among Wall Street analysts.

Gevo's stock was trading at $4.28 at the start of the year. Since then, GEVO stock has decreased by 15.9% and is now trading at $3.60.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our GEVO earnings forecast.

Gevo, Inc. (NASDAQ:GEVO) posted its quarterly earnings data on Wednesday, November, 10th. The energy company reported ($0.07) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.07). The energy company earned $0.14 million during the quarter, compared to analyst estimates of $0.27 million. Gevo had a negative trailing twelve-month return on equity of 10.36% and a negative net margin of 11,552.61%. During the same quarter in the previous year, the company earned ($0.08) earnings per share.

Gevo's stock reverse split on the morning of Monday, June 4th 2018. The 1-20 reverse split was announced on Friday, June 1st 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 1st 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

7 employees have rated Gevo Chief Executive Officer Patrick Gruber on Glassdoor.com. Patrick Gruber has an approval rating of 15% among the company's employees. This puts Patrick Gruber in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Gevo investors own include Bionano Genomics (BNGO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Matinas BioPharma (MTNB), Denison Mines (DNN), Novan (NOVN) and CBL & Associates Properties (CBL).

Gevo trades on the NASDAQ under the ticker symbol "GEVO."

Gevo's stock is owned by a number of retail and institutional investors. Top institutional investors include State Street Corp (15.01%), Rafferty Asset Management LLC (1.47%), Millennium Management LLC (1.32%), Grantham Mayo Van Otterloo & Co. LLC (1.13%), Northern Trust Corp (0.88%) and Credit Suisse AG (0.71%). Insiders that own company stock include Christopher Michael Ryan, Gary W Mize, Geoffrey Thomas Jr Williams, L Lynn Smull, Patrick R Gruber and Timothy J Cesarek.
View institutional ownership trends.

Shares of GEVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GEVO stock can currently be purchased for approximately $3.60.

Gevo (NASDAQ:GEVO) has a market capitalization of $846.61 million and generates $710,000.00 in revenue each year. The energy company earns $-59,200,000.00 in net income (profit) each year or ($0.29) on an earnings per share basis.

Gevo's mailing address is 345 Inverness Drive South Building C Suite 310, Englewood CO, 80112. The official website for the company is www.gevo.com. The energy company can be reached via phone at (303) 858-8358 or via email at info@integra-ir.com.